FR 122047

Drug Profile

FR 122047

Alternative Names: ASP 6537

Latest Information Update: 26 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Fujisawa
  • Class Antiplatelets; Small molecules
  • Mechanism of Action Cyclo-oxygenase 1 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Pain; Rheumatoid arthritis; Thrombosis

Most Recent Events

  • 08 Oct 2001 No-Development-Reported for Pain in Japan (PO)
  • 15 May 2000 Preclinical development for Pain in Japan (PO)
  • 15 May 2000 A study has been added to the Pain Control pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top